PACS Group Shares Soar 50% Amid S-8 Filing and Hindenburg Probe

Introduction

PACS Group Inc (NYSE: PACS), trading at $25.27 as of November 20, 2025, shows a 50.15% increase in share price over its previous close. The company operates as a holding entity investing in post-acute healthcare facilities, professionals, and ancillary services. PACS Group’s common stock is listed on the New York Stock Exchange under the ticker PACS, with a trading volume of 163,044 shares on November 20.

Corporate Structure and Leadership

Founded in 2013, PACS Group oversees 316 independent subsidiaries across 17 states, serving more than 30,000 patients each day. The leadership team comprises five executives with over 50 years of combined experience in healthcare and skilled nursing administration. Co-founders Jason Murray (CEO and Chairman) and Mark Hancock (Executive Vice Chairman and Interim CFO) bring more than two decades each in clinical operations and finance. On November 19, 2025, the company filed a Form S-8 registering securities under its 2024 Incentive Award Plan and Employee Stock Purchase Plan to align employee interests with shareholder value.

Healthcare Facilities by Martha Dominguez de Gouveia

Recent Developments and News

On April 11, 2024, PACS Group closed its initial public offering, selling 21,428,572 shares at $21.00 per share for gross proceeds of approximately $450 million; underwriters exercised their 30-day option to purchase an additional 3,214,284 shares.
On November 4, 2024, Hindenburg Research published a report alleging that PACS Group improperly converted residents to Medicare Part A coverage during the public health emergency. Subsequently, federal authorities issued civil investigative demands regarding the company’s reimbursement and referral practices.
In November 2024, PACS Group released preliminary results for the quarter ended September 30, 2024, reporting total portfolio occupancy of 90.5%—compared to an industry average of 77%—and ending the period with more than $600 million in cash and available liquidity. Ramp-up facilities achieved 93.9% occupancy, mature facilities 94.5% occupancy, and 76% of skilled nursing locations received 4- or 5-star CMS quality ratings.
On November 19, 2025, the company filed an 8-K reporting material events and submitted its Quarterly Report on Form 10-Q for the period ended September 30, 2025.

Financial and Strategic Analysis

For the twelve months ended September 30, 2025, PACS Group reported revenue of $3.56 billion and net income attributable to common shareholders of $92.29 million, reflecting a profit margin of 2.59%. The trailing P/E stood at 27.59, while the forward P/E ratio was 7.51 and the PEG ratio 0.50. The balance sheet showed total cash of $73.37 million against a debt-to-equity ratio of 469.36%. Enterprise value reached $5.21 billion, translating to EV/Revenue of 1.46 and EV/EBITDA of 24.11.
Strategically, PACS Group continues to expand through acquisitions, adding 56 facilities in six new states during Q3 2024. The company’s equity incentive programs—outlined in the November 19, 2025 S-8 filing—aim to retain key personnel and align workforce performance with long-term business objectives.

Market Position and Industry Context

PACS Group ranks among the largest post-acute care platforms in the United States. Operating 316 skilled nursing facilities and affiliated ancillary services, the company maintains higher occupancy and above-average CMS quality ratings compared with sector benchmarks. In the broader skilled nursing market, shifting payor mix and regulatory scrutiny—particularly around Medicare Part A eligibility—remain key industry considerations.

TL;DR

PACS Group closed its IPO on April 11, 2024, raising approximately $450 million, and has continued to expand its footprint through acquisitions. Allegations published on November 4, 2024, by Hindenburg Research prompted federal inquiries into Medicare billing practices; PACS Group has received civil investigative demands and is cooperating with authorities. Operational metrics for Q3 2024 showed 90.5% overall occupancy and over $600 million in liquidity. On November 19, 2025, the company registered shares for employee incentive plans under a Form S-8. The one-year price target stands at $34.67, with a forward P/E of 7.51.